- Home
- WAI vs TPST Comparison
WAI vs TPST Comparison
Compare WAI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- TPST
- Stock Information
- Founded
- WAI 2018
- TPST 2011
- Country
- WAI China
- TPST United States
- Employees
- WAI N/A
- TPST N/A
- Industry
- WAI
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- TPST Health Care
- Exchange
- WAI NYSE
- TPST Nasdaq
- Market Cap
- WAI 8.1M
- TPST 33.0M
- IPO Year
- WAI 2023
- TPST N/A
- Fundamental
- Price
- WAI $0.43
- TPST $6.66
- Analyst Decision
- WAI
- TPST Hold
- Analyst Count
- WAI 0
- TPST 3
- Target Price
- WAI N/A
- TPST $30.00
- AVG Volume (30 Days)
- WAI 1.9M
- TPST 72.4K
- Earning Date
- WAI 08-24-2025
- TPST 08-07-2025
- Dividend Yield
- WAI N/A
- TPST N/A
- EPS Growth
- WAI N/A
- TPST N/A
- EPS
- WAI N/A
- TPST N/A
- Revenue
- WAI $3,750,352.00
- TPST N/A
- Revenue This Year
- WAI N/A
- TPST N/A
- Revenue Next Year
- WAI N/A
- TPST N/A
- P/E Ratio
- WAI N/A
- TPST N/A
- Revenue Growth
- WAI N/A
- TPST N/A
- 52 Week Low
- WAI $0.41
- TPST $5.35
- 52 Week High
- WAI $20.00
- TPST $29.38
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- TPST 42.36
- Support Level
- WAI N/A
- TPST $6.57
- Resistance Level
- WAI N/A
- TPST $7.05
- Average True Range (ATR)
- WAI 0.00
- TPST 0.26
- MACD
- WAI 0.00
- TPST -0.06
- Stochastic Oscillator
- WAI 0.00
- TPST 8.45
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.